Washington Trust Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Washington Trust Advisors, Inc.
- $1.09 Billion
- Q1 2025
A detailed history of Washington Trust Advisors, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 820 shares of ARWR stock, worth $13,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
820
Previous 820
-0.0%
Holding current value
$13,587
Previous $15,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$260 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$219 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$184 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$116 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$86.7 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.75B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...